Detalhe da pesquisa
1.
Corrigendum to 'National Heart Foundation of Australia & Cardiac Society of Australia and New Zealand: Australian Clinical Guidelines for the Management of Acute Coronary Syndromes 2016' Heart Lung and Circulation volume 25, (2016) 898 - 952.
Heart Lung Circ;
26(10): 1117, 2017 10.
Artigo
em Inglês
| MEDLINE
| ID: mdl-28867028
2.
Impact of a regionalised clinical cardiac support network on mortality among rural patients with myocardial infarction.
Med J Aust;
200(3): 157-60, 2014 Feb 17.
Artigo
em Inglês
| MEDLINE
| ID: mdl-24528431
3.
The prognostic meaning of the full spectrum of aVR ST-segment changes in acute myocardial infarction.
Eur Heart J;
33(3): 384-92, 2012 Feb.
Artigo
em Inglês
| MEDLINE
| ID: mdl-21856681
4.
aVR ST elevation: an important but neglected sign in ST elevation acute myocardial infarction.
Eur Heart J;
31(15): 1845-53, 2010 Aug.
Artigo
em Inglês
| MEDLINE
| ID: mdl-20513728
5.
National Heart Foundation of Australia & Cardiac Society of Australia and New Zealand: Australian Clinical Guidelines for the Management of Acute Coronary Syndromes 2016.
Heart Lung Circ;
25(9): 895-951, 2016 09.
Artigo
em Inglês
| MEDLINE
| ID: mdl-27476580
6.
Enoxaparin versus unfractionated heparin in elective percutaneous coronary intervention.
N Engl J Med;
355(10): 1006-17, 2006 Sep 07.
Artigo
em Inglês
| MEDLINE
| ID: mdl-16957147
7.
Risk stratification of patients with acute anterior myocardial infarction and right bundle-branch block: importance of QRS duration and early ST-segment resolution after fibrinolytic therapy.
Circulation;
114(8): 783-9, 2006 Aug 22.
Artigo
em Inglês
| MEDLINE
| ID: mdl-16908761
8.
Comparison of percutaneous coronary intervention and coronary artery bypass grafting after acute myocardial infarction complicated by cardiogenic shock: results from the Should We Emergently Revascularize Occluded Coronaries for Cardiogenic Shock (SHOCK) trial.
Circulation;
112(13): 1992-2001, 2005 Sep 27.
Artigo
em Inglês
| MEDLINE
| ID: mdl-16186436
9.
Mortality and morbidity remain high despite captopril and/or Valsartan therapy in elderly patients with left ventricular systolic dysfunction, heart failure, or both after acute myocardial infarction: results from the Valsartan in Acute Myocardial Infarction Trial (VALIANT).
Circulation;
112(22): 3391-9, 2005 Nov 29.
Artigo
em Inglês
| MEDLINE
| ID: mdl-16301343
10.
Patients with prolonged ischemic chest pain and presumed-new left bundle branch block have heterogeneous outcomes depending on the presence of ST-segment changes.
J Am Coll Cardiol;
46(1): 29-38, 2005 Jul 05.
Artigo
em Inglês
| MEDLINE
| ID: mdl-15992631
11.
Efficacy and safety of enoxaparin compared with unfractionated heparin in high-risk patients with non-ST-segment elevation acute coronary syndrome undergoing percutaneous coronary intervention in the Superior Yield of the New Strategy of Enoxaparin, Revascularization and Glycoprotein IIb/IIIa Inhibitors (SYNERGY) trial.
Am Heart J;
152(6): 1042-50, 2006 Dec.
Artigo
em Inglês
| MEDLINE
| ID: mdl-17161049
12.
Baseline Q-wave surpasses time from symptom onset as a prognostic marker in ST-segment elevation myocardial infarction patients treated with primary percutaneous coronary intervention.
J Am Coll Cardiol;
53(17): 1503-9, 2009 Apr 28.
Artigo
em Inglês
| MEDLINE
| ID: mdl-19389560
13.
Enoxaparin versus unfractionated heparin in elective percutaneous coronary intervention 1-year results from the STEEPLE (SafeTy and efficacy of enoxaparin in percutaneous coronary intervention patients, an international randomized evaluation) trial.
JACC Cardiovasc Interv;
2(11): 1083-91, 2009 Nov.
Artigo
em Inglês
| MEDLINE
| ID: mdl-19926048
14.
Impact of anticoagulation levels on outcomes in patients undergoing elective percutaneous coronary intervention: insights from the STEEPLE trial.
Eur Heart J;
29(4): 462-71, 2008 Feb.
Artigo
em Inglês
| MEDLINE
| ID: mdl-18276619